Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study-Reference-Cited by-同舟云学术

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Published:2024-02 Issue:10427 Volume:403 Page:632-644
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Weber Jeffrey S,Carlino Matteo S,Khattak Adnan,Meniawy Tarek,Ansstas George,Taylor Matthew H,Kim Kevin B,McKean Meredith,Long Georgina V,Sullivan Ryan J,Faries Mark,Tran Thuy T,Cowey C Lance,Pecora Andrew,Shaheen Montaser,Segar Jennifer,Medina Theresa,Atkinson Victoria,Gibney Geoffrey T,Luke Jason J,Thomas Sajeve,Buchbinder Elizabeth I,Healy Jane A,Huang Mo,Morrissey Manju,Feldman Igor,Sehgal Vasudha,Robert-Tissot Celine,Hou Peijie,Zhu Lili,Brown Michelle,Aanur Praveen,Meehan Robert S,Zaks Tal

Funder

Moderna Therapeutics Inc

Publisher

Elsevier BV

Reference30 articles.

1. mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer;Cafri;J Clin Invest,2020

2. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma;Van Allen;Science,2015

3. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial;Vansteenkiste;Lancet Oncol,2016

4. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801;Kirkwood;J Clin Oncol,2001

5. An immunogenic personal neoantigen vaccine for patients with melanoma;Ott;Nature,2017

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A recent perspective on designing tumor vaccines for tumor immunology;International Immunopharmacology;2024-12

2. Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery;International Journal of Pharmaceutics: X;2024-12

3. Self-assembling nanoparticles for miRNA delivery towards precision medicine against melanoma;Journal of Drug Delivery Science and Technology;2024-11

4. Advances in Vaccines for Melanoma;Hematology/Oncology Clinics of North America;2024-10

5. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy;Hematology/Oncology Clinics of North America;2024-10